Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Fludarabine (Primary) ; Haematopoietic stem cell therapy
- Indications Sickle cell anaemia; Thalassaemia
- Focus Therapeutic Use
- 17 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 05 Dec 2016 Status changed from suspended to recruiting.
- 05 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.